Approved Use:
KISQALI® (ribociclib) is a prescription medicine used in combination with a certain type of medicine as the first hormonal-based therapy to treat women who have gone through menopause with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negati... See More
I start this in a couple of weeks.
The drug has proved to be very successful in treatment of stage IV breast cancer Hoping that it proves to be a total success
Thank you. After being stage 4 and taking arimidex i was stable for 3 years, now I have a walnut size active cancer in my upper right lung again. I dont do well when meds lower my counts. Ibrance sent me into neutropenia, extreme fatigue, stomatitis and pneumonitis to name a few SE's. I hope Kisqale is easier on my body.
Missy , keep us informed. Can't wait to hear this new story. Happy for you
Thank you, i will!
I heard about this thru the San Antonio conference. This is very exciting. Another Ibrance like drug. Similar in the new way that it works and in the results
I believe that they are claiming that Kisqale doesn't effect your white blood count so much
kisqali experience
New treatment just approved by the FDA 
Kisqali and Insurance Company
FDA Approved Oral SERD - Elacestrant (ORSERDU) 1/27/23!!!
Kisqali and EKG
